The collective discussion demonstrates strong agreement with the publication, as evident in statements like 'Cancer patients are a high risk population' and the emphasis on vaccination prioritization. The tone and choice of words, such as 'high risk' and 'should be prioritized,' reflect the perceived importance and urgency of protecting vulnerable patients, contributing to a view that these social discussions could influence healthcare practices.
AgreementStrong agreement
Most discussions strongly agree with the article, emphasizing that cancer patients should be prioritized for vaccination.
InterestHigh interest
Posts show high interest, referencing specific authors and the importance of vaccination in vulnerable groups.
EngagementModerate engagement
While one post directly supports the publication, the engagement remains moderate due to limited diversity of responses.
ImpactHigh impact
The focus on prioritization and protection highlights that these discussions have significant implications for health policy and patient care.
Abstract in brief
Patients with cancer are at higher risk for severe COVID-19, highlighting the urgent need for safe and effective vaccines.
Evidence suggests most cancer patients should receive COVID-19 vaccines, but careful monitoring of safety and effectiveness in this group is essential.
Special attention is needed for patients undergoing active treatment, with ongoing research to assess the timing and impact of vaccination in relation to cancer therapies.]
Cancer patients are a high risk population for #COVID-19 complications and should be prioritized to receive the vaccine. Commentary by @NicoleKuderer @gary_lyman
Feb 21, 2021 · 2 likes · 2 shares · 620 followersView post →
RG
Raffaele Giusti
@oncoblogger · X
Challenges and Opportunities for #COVID19 #Vaccines in Patients with #Cancer https://t.co/3g7ZdqN89c
Feb 22, 2021 · 1 like · 1,517 followersView post →
KM
Krishan Maggon
@kkmaggon · X
Challenges and Opportunities for COVID-19 Vaccines in Patients with Cancer https://t.co/tUi1BmBZUw
This video discusses COVID-19 vaccine safety for immunocompromised individuals, emphasizing that most cancer patients should receive vaccinations as benefits likely outweigh risks, despite their compromised immune…
This video discusses COVID-19 vaccine safety for immunocompromised individuals, especially cancer patients. The benefits of vaccination likely outweigh the risks, with evidence supporting their effectiveness despite…
RT @diegoah66: Cancer patients are a high risk population for #COVID-19 complications and should be prioritized to receive the vaccine. Com…
Feb 22, 2021 · 2 shares · 232 followersView post →
RG
Raffaele Giusti
@oncoblogger · X
Challenges and Opportunities for #COVID19 #Vaccines in Patients with #Cancer https://t.co/3g7ZdqN89c
Feb 22, 2021 · 1 like · 1,517 followersView post →
DM
Diego Adrianzen-Herrera, MD, MS
@diegoah66 · X
Cancer patients are a high risk population for #COVID-19 complications and should be prioritized to receive the vaccine. Commentary by @NicoleKuderer @gary_lyman
Feb 21, 2021 · 2 likes · 2 shares · 620 followersView post →
N
COVID-19 Cancer Registry Insights | PDF | Hematopoietic Stem Cell ...
News
Published online February 3, 2021:1–19. doi:10.1080/07357907.2021.1885596 15. Lyman GH, Kuderer NM. Randomized Controlled Trials Versus Real-World Data in ...